.Z.ebranie naukowe 29.06.2026 – dr Grzegorz Burnat

Tytuł prezentacji:

„Functional characterization of muscarinic M1/M3/M5 and mGluR2/4/7 receptor interactions in heterologous expression systems”

Proponowane piśmiennictwo:

1. Chruścicka, B., Burnat, G., Brański, P., Chorobik, P., Lenda, T., Marciniak, M., & Pilc, A. (2015). Tetracycline-based system for controlled inducible expression of group III metabotropic glutamate receptors. Journal of biomolecular screening, 20(3), 350–358. https://doi.org/10.1177/1087057114559183
2. Babii, Y., Pałucha-Poniewiera, A., Bobula, B., Kania, A., Bederska-Łojewska, D., Brański, P., & Pilc, A. (2025). Coadministration of scopolamine and mGlu2 NAM VU6001966 as a novel antidepressant approach: Lowering effective dose and reducing cognitive side effects. Psychopharmacology, 10.1007/s00213-025-06916-6. Advance online publication. https://doi.org/10.1007/s00213-025-06916-6
3. Pytka, K., Dziubina, A., Młyniec, K., Dziedziczak, A., Żmudzka, E., Furgała, A., Olczyk, A., Sapa, J., & Filipek, B. (2016). The role of glutamatergic, GABA-ergic, and cholinergic receptors in depression and antidepressant-like effect. Pharmacological reports : PR, 68(2), 443–450. https://doi.org/10.1016/j.pharep.2015.10.006